Ralf Kraehmer

Title: Ralf Kraehmer: Innovator in Biomolecular Technologies

Introduction

Ralf Kraehmer is a notable inventor based in Panketal, Germany. He has made significant contributions to the field of biomolecular technologies, holding two patents that showcase his innovative approach to biomolecule immobilization and multimeric conjugates.

Latest Patents

Kraehmer's latest patents include a method for the immobilization of biomolecules and a multimeric conjugate. The first patent describes a method that involves contacting a modified metal surface with biomolecules containing sulfhydryl groups. This process includes irradiating the surface with UV radiation in the presence of a photo-initiator. The metal surface is modified with a cross-linker compound that has a terminal thiol or dithiol group, enhancing the immobilization process. The second patent focuses on a multimeric agent and its conjugate with a biologically active agent. These multimeric conjugates are designed to have a longer lifespan in vivo and increased avidity compared to unmodified biologically active agents. The invention also outlines the use of these conjugates for diagnostic and therapeutic purposes.

Career Highlights

Throughout his career, Ralf Kraehmer has worked with several companies, including Celares GmbH and Scil Proteins GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in biomolecular applications.

Collaborations

Kraehmer has collaborated with notable professionals in his field, including Frank Leenders and Erik Fiedler. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Ralf Kraehmer's work in biomolecular technologies exemplifies the impact of innovation in scientific research. His patents reflect a commitment to advancing the field and improving the applications of biomolecules in various industries.